- Home
- RUBI vs PPCB Comparison
RUBI vs PPCB Comparison
Compare RUBI & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RUBI | PPCB |
|---|---|---|
| Founded | 2022 | 2007 |
| Country | Greece | Australia |
| Employees | N/A | N/A |
| Industry | Marine Transportation | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7M | 2.6M |
| IPO Year | 2022 | 2011 |
Fundamental Metrics
Financial Performance| Metric | RUBI | PPCB |
|---|---|---|
| Price | $1.13 | $0.53 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 261.3K | 238.1K |
| Earning Date | 05-06-2020 | 05-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.19 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.13 | $0.06 |
| 52 Week High | $6.69 | $6.79 |
Technical Indicators
Market Signals| Indicator | RUBI | PPCB |
|---|---|---|
| Relative Strength Index (RSI) | 27.99 | 34.21 |
| Support Level | $0.86 | $0.12 |
| Resistance Level | $1.35 | $1.29 |
| Average True Range (ATR) | 0.20 | 0.08 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 11.21 | 1.54 |
Price Performance
Historical ComparisonAbout RUBI Rubico Inc.
Rubico Inc is an international provider of crude oil transportation services. The Company is engaged in the ownership and operation of a fleet of tanker vessels designed for enhanced fuel efficiency and reduced greenhouse gas emissions, incorporating environmentally friendly technologies.
About PPCB Propanc Biopharma Inc.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.